StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho cash

Cash and short-term investments held at the end of each period.

QuidelOrtho's cash was $166.40M at Sep 27, 2026. For fiscal 2025 it was $169.80M, up 72.4% from the year before. The highest annual figure on record is $828.50M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 28, 2025$169.80M+72.4%
FY2024Dec 29, 2024$98.50M-41.3%
FY2023Dec 31, 2023$167.90M-51.5%
FY2022Jan 1, 2023$346.00M-58.2%
FY2021Jan 2, 2022$828.50M+69.1%
FY2020Jan 3, 2021$489.90M+827.8%
FY2019Dec 29, 2019$52.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$166.40M+69.6%
Q2 FY2026Jun 28, 2026$123.40M-18.7%
Q1 FY2026Mar 29, 2026$140.40M+10.4%
Q4 FY2025Dec 28, 2025$169.80M+72.4%
Q3 FY2025Sep 28, 2025$98.10M-31.9%
Q2 FY2025Jun 29, 2025$151.70M+41.1%
Q1 FY2025Mar 30, 2025$127.20M+61.0%
Q4 FY2024Dec 29, 2024$98.50M-41.3%
Q3 FY2024Sep 29, 2024$144.00M-25.7%
Q2 FY2024Jun 30, 2024$107.50M-52.2%
Q1 FY2024Mar 31, 2024$79.00M-80.1%
Q4 FY2023Dec 31, 2023$167.90M-51.5%
Q3 FY2023Oct 1, 2023$193.80M-26.9%
Q2 FY2023Jul 2, 2023$224.70M-48.1%
Q1 FY2023Apr 2, 2023$397.70M-68.8%
Q4 FY2022Jan 1, 2023$346.00M-58.2%
Q3 FY2022Oct 2, 2022$265.00M-54.2%
Q2 FY2022Jul 3, 2022$433.10M-27.0%
Q1 FY2022Apr 3, 2022$1.28B+160.4%
Q4 FY2021Jan 2, 2022$828.50M+1469.1%
Q3 FY2021Oct 3, 2021$578.40M–
Q2 FY2021Jul 4, 2021$593.20M–
Q4 FY2020Jan 3, 2021$489.90M–
Q4 FY2019Dec 29, 2019$52.80M–

More QuidelOrtho figures

See a number that looks wrong?